imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce

This study is testing whether a telemedicine and patient guidance program can improve how consistently patients with pulmonary arterial hypertension (PAH — a condition causing high blood pressure in the arteries of the lungs) take their prescribed medications, ultimately improving outcomes. **You may be eligible if...** - You are 18 years of age or older - You have been diagnosed with pulmonary arterial hypertension (WHO Group 1 PAH) - You have been on stable oral PAH treatment for at least 4 weeks before enrolling - You have access to a phone or internet connection for remote teleconsultations **You may NOT be eligible if...** - You have a different form of pulmonary hypertension (Groups 2–5) - You started a new PAH medication less than 4 weeks ago - You do not have access to a phone or internet - You are currently in a hospital or have been recently hospitalized for PAH-related reasons Talk to your doctor to see if this trial is right for you.